Forte Biosciences, Inc. (FBRX)
20.07
-0.90
(-4.29%)
USD |
NASDAQ |
May 19, 16:00
20.01
-0.06
(-0.30%)
After-Hours: 20:00
Forte Biosciences Total Assets (Quarterly) : 67.22M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.605B |
| Agenus, Inc. | 186.46M |
| Alnylam Pharmaceuticals, Inc. | 5.130B |
| Amgen, Inc. | 92.50B |
| Anika Therapeutics, Inc. | 179.39M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 25.12M |
| Shareholders Equity (Quarterly) | 42.10M |
| Current Ratio | 2.753 |